A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis
Clinical trial NCT03117270 · COMPLETED
Trial details
- NCT number
- NCT03117270
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2018-07-02
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.